Marius Hittinger - Publications

Nano-in-micro dry powder formulations combining azithromycin and menadione as adjuvant against pulmonary P. aeruginosa infections.

Journal: International journal of pharmaceutics

Published: March 11, 2026

Proteomic profiling of macrophages: effects of inflammatory activation and anti-inflammatory treatment with IBD therapeutics.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: July 10, 2025

Procognitive Potential of Neuroprotective Triazine 5-HT6 Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological Profile.

Journal: ACS chemical neuroscience

Published: February 28, 2025

Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease.

Journal: Drug discovery today

Published: January 31, 2024

First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: January 08, 2024

Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations.

Journal: International journal of pharmaceutics

Published: May 26, 2023

The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 15, 2023

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection.

Journal: Antimicrobial agents and chemotherapy

Published: January 17, 2023

Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay.

Journal: In vitro models

Published: January 01, 2022

Method for measuring mucoadhesion of ophthalmica considering regulatory aspects.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: October 07, 2021

Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties.

Journal: Advanced drug delivery reviews

Published: September 13, 2021

In vitro tools for orally inhaled drug products-state of the art for their application in pharmaceutical research and industry and regulatory challenges.

Journal: In vitro models

Published: September 02, 2021